Elebaid 4B Hypothesis: A Proposed Epigenetic Model

Title: Elebaid 4B Hypothesis: A Testable Epigenetic Model Linking Behavioral Interventions to Expression of Four Candidate Genes. Author: Elebaid Mohammed Yousif Elhaj Field: Molecular Biology / Behavioral Epigenetics Affiliation: University of Gezira, Sudan. Origin: Shendi, River Nile State. Abstract: This preprint presents a testable theoretical framework in molecular biology. It hypothesizes that consistent behavioral interventions may correlate with altered expression and methylation status of four candidate genes. The four proposed molecular gateways are: B1 - BDNF (Brain-Derived Neurotrophic Factor): Marker for neuroplasticity. Hypothesis: upregulation. B2 - NR3C1 (Glucocorticoid Receptor Gene): Marker for HPA-axis regulation. Hypothesis: decreased promoter methylation (exon 1F). B3 - IL6 (Interleukin-6): Marker for low-grade inflammation. Hypothesis: downregulation. B4 - OXTR (Oxytocin Receptor Gene): Marker for social bonding. Hypothesis: decreased promoter methylation. Proposed quantitative index for pilot testing: E4B Score = (BDNF_mRNA * OXTR_mRNA) / (NR3C1_methylation_% + IL6_mRNA) Note: This is a proposed composite index for discussion, requires empirical validation. Proposed Molecular Methods for Validation: 1. Sample: Saliva/Blood. 2. DNA methylation: Bisulfite sequencing / Methylation-specific qPCR for NR3C1 and OXTR promoters. 3. Gene expression: RT-qPCR for BDNF and IL6 mRNA. 4. Protein level: ELISA for salivary cortisol and serum BDNF. Current Status: Theoretical model. No clinical or therapeutic claims. Model is presented for falsification and further experimental validation. Keywords: Molecular Biology, Epigenetics, DNA Methylation, BDNF, NR3C1, IL6, OXTR, RT-qPCR, Bisulfite Sequencing, Behavioral Epigenetics. License: CC-BY 4.0 (or All Rights Reserved as selected by author) DOI: 10.5281/zenodo.23772567 Date: October 29, 2026 - Shendi, Sudan.